CIZ — Cizzle Biotechnology Holdings Income Statement
0.000.00%
Last trade - 00:00
- £6.54m
- £6.09m
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.323 | 0.832 | 0.306 | 3.96 | 0.963 |
Operating Profit | -0.323 | -0.832 | -0.306 | -3.96 | -0.963 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.323 | -0.832 | -0.306 | -3.96 | -0.963 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.323 | -0.832 | -0.306 | -3.92 | -0.912 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.06 | -0.832 | -0.306 | -3.92 | -0.912 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.06 | -0.832 | -0.306 | -3.92 | -0.912 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0 | -0.001 | -0.012 | -0.003 |